| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
33,803 |
31,699 |
$3.62M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
20,873 |
19,226 |
$2.67M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,837 |
6,178 |
$919K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
13,612 |
11,529 |
$612K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,445 |
6,085 |
$580K |
| 0240U |
|
3,513 |
3,090 |
$315K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,814 |
1,705 |
$207K |
| 71045 |
Radiologic examination, chest; single view |
3,761 |
3,431 |
$198K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
6,086 |
1,239 |
$187K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,161 |
3,382 |
$185K |
| 70450 |
Computed tomography, head or brain; without contrast material |
451 |
420 |
$184K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,669 |
1,524 |
$181K |
| G0330 |
Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room |
101 |
73 |
$156K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,970 |
2,692 |
$144K |
| 80053 |
Comprehensive metabolic panel |
17,930 |
16,265 |
$132K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,667 |
4,231 |
$128K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
20,256 |
18,210 |
$112K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
161 |
145 |
$102K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,247 |
2,966 |
$95K |
| 80050 |
General health panel |
2,265 |
2,168 |
$95K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,302 |
5,812 |
$94K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,460 |
2,289 |
$91K |
| 71046 |
Radiologic examination, chest; 2 views |
1,543 |
1,430 |
$91K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,884 |
3,584 |
$83K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
108 |
101 |
$79K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,345 |
1,068 |
$78K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,616 |
5,148 |
$76K |
| 80061 |
Lipid panel |
5,885 |
5,549 |
$67K |
| 36415 |
Collection of venous blood by venipuncture |
28,505 |
25,464 |
$66K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,364 |
1,955 |
$66K |
| J3490 |
Unclassified drugs |
7,429 |
4,707 |
$64K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
508 |
487 |
$60K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,759 |
1,324 |
$58K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
2,602 |
2,367 |
$55K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,444 |
1,964 |
$54K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
722 |
533 |
$45K |
| 81025 |
|
5,645 |
5,215 |
$42K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,212 |
1,143 |
$42K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,198 |
1,152 |
$41K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,243 |
957 |
$39K |
| 81001 |
|
15,865 |
14,358 |
$35K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
43 |
41 |
$35K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,296 |
4,018 |
$31K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
101 |
95 |
$27K |
| 86780 |
|
2,394 |
2,161 |
$27K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,125 |
292 |
$24K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
852 |
777 |
$22K |
| 87449 |
|
1,804 |
1,719 |
$22K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
354 |
323 |
$21K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
620 |
548 |
$19K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
2,511 |
1,775 |
$17K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,211 |
242 |
$16K |
| 84439 |
|
1,929 |
1,743 |
$16K |
| 86803 |
|
1,280 |
1,160 |
$15K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
297 |
234 |
$14K |
| 86762 |
|
1,154 |
1,034 |
$14K |
| 74018 |
|
57 |
53 |
$13K |
| 86787 |
|
1,126 |
995 |
$12K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,243 |
1,130 |
$12K |
| 87400 |
|
916 |
419 |
$11K |
| 84484 |
|
1,688 |
1,376 |
$11K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
451 |
409 |
$11K |
| 87340 |
|
1,242 |
1,116 |
$11K |
| 86850 |
|
1,435 |
1,104 |
$10K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
214 |
203 |
$10K |
| 87081 |
|
1,519 |
1,451 |
$10K |
| J2704 |
Injection, propofol, 10 mg |
268 |
224 |
$10K |
| 87088 |
|
1,559 |
1,407 |
$9K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
464 |
414 |
$9K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
924 |
830 |
$9K |
| 85027 |
|
1,829 |
1,749 |
$9K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,545 |
1,410 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
241 |
237 |
$8K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
56 |
51 |
$8K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
155 |
151 |
$8K |
| 83690 |
|
1,276 |
1,164 |
$6K |
| 90686 |
|
91 |
89 |
$6K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
259 |
215 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
99 |
93 |
$5K |
| 74019 |
|
53 |
50 |
$4K |
| 84702 |
|
268 |
200 |
$4K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
45 |
39 |
$4K |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
70 |
66 |
$3K |
| 82607 |
|
245 |
221 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
116 |
109 |
$3K |
| 86900 |
|
1,305 |
1,166 |
$3K |
| 86901 |
|
1,306 |
1,166 |
$3K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
286 |
264 |
$3K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
221 |
207 |
$3K |
| A9150 |
Non-prescription drugs |
633 |
539 |
$3K |
| 76830 |
Ultrasound, transvaginal |
13 |
13 |
$3K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
54 |
50 |
$3K |
| 82553 |
|
458 |
415 |
$3K |
| 83880 |
|
145 |
131 |
$3K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
488 |
444 |
$2K |
| 83735 |
|
636 |
568 |
$2K |
| 99205 |
Prolong outpt/office vis |
43 |
42 |
$2K |
| 82550 |
|
604 |
544 |
$2K |
| J7510 |
Prednisolone oral, per 5 mg |
278 |
263 |
$2K |
| 72100 |
|
26 |
24 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
119 |
114 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
293 |
269 |
$2K |
| 90715 |
|
14 |
12 |
$2K |
| 82950 |
|
384 |
346 |
$2K |
| 82043 |
|
338 |
311 |
$2K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
680 |
631 |
$1K |
| 73030 |
|
15 |
12 |
$1K |
| 83021 |
|
102 |
83 |
$1K |
| 82947 |
|
351 |
294 |
$1K |
| 82077 |
|
113 |
104 |
$1K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
241 |
218 |
$1K |
| 84153 |
|
77 |
74 |
$1K |
| 83020 |
|
113 |
83 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
13 |
13 |
$1K |
| 84144 |
|
68 |
51 |
$1K |
| 86592 |
|
228 |
206 |
$958.47 |
| 82150 |
|
193 |
174 |
$898.38 |
| 86141 |
|
89 |
86 |
$738.57 |
| 97161 |
|
12 |
12 |
$707.28 |
| 82570 |
|
160 |
147 |
$704.48 |
| 83550 |
|
68 |
63 |
$679.78 |
| 87077 |
|
120 |
89 |
$675.66 |
| 85660 |
|
124 |
121 |
$671.02 |
| 82728 |
|
38 |
36 |
$605.88 |
| 87184 |
|
142 |
109 |
$578.88 |
| 80074 |
|
13 |
12 |
$523.93 |
| J1644 |
Injection, heparin sodium, per 1000 units |
22 |
12 |
$518.33 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
13 |
12 |
$510.15 |
| 72040 |
|
12 |
12 |
$499.04 |
| 73130 |
|
14 |
12 |
$493.20 |
| 83540 |
|
69 |
64 |
$473.41 |
| 81511 |
|
40 |
36 |
$433.73 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
56 |
53 |
$338.95 |
| 87420 |
|
24 |
24 |
$329.72 |
| 82677 |
|
12 |
12 |
$328.35 |
| 84436 |
|
51 |
48 |
$315.84 |
| J2060 |
Injection, lorazepam, 2 mg |
32 |
27 |
$314.67 |
| 80320 |
|
71 |
67 |
$300.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
26 |
24 |
$293.45 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
29 |
26 |
$283.19 |
| 80179 |
|
19 |
19 |
$279.60 |
| 80305 |
|
24 |
24 |
$277.20 |
| 82105 |
|
12 |
12 |
$227.81 |
| 84481 |
|
19 |
17 |
$215.29 |
| 86336 |
|
12 |
12 |
$211.64 |
| 85610 |
|
120 |
100 |
$208.91 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
14 |
14 |
$169.13 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
26 |
25 |
$168.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
62 |
45 |
$129.96 |
| 99152 |
|
15 |
12 |
$129.66 |
| 81003 |
|
80 |
73 |
$119.25 |
| 85379 |
|
13 |
12 |
$100.48 |
| 86140 |
|
14 |
13 |
$91.52 |
| 84479 |
|
14 |
12 |
$75.84 |
| 80076 |
|
12 |
12 |
$65.36 |
| 82962 |
|
23 |
16 |
$54.23 |
| 82270 |
|
14 |
14 |
$52.56 |
| 82272 |
|
15 |
12 |
$50.76 |
| 99386 |
|
13 |
12 |
$44.29 |
| 3016F |
|
27 |
27 |
$0.00 |
| 87631 |
|
185 |
167 |
$0.00 |
| 02404 |
|
73 |
71 |
$0.00 |
| 3078F |
|
40 |
37 |
$0.00 |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
12 |
12 |
$0.00 |
| 3077F |
|
21 |
20 |
$0.00 |
| A9270 |
Non-covered item or service |
384 |
243 |
$0.00 |
| 3080F |
|
13 |
12 |
$0.00 |
| 3075F |
|
18 |
18 |
$0.00 |
| 3074F |
|
58 |
54 |
$0.00 |
| 3079F |
|
55 |
52 |
$0.00 |
| 1170F |
|
99 |
92 |
$0.00 |
| 99385 |
|
29 |
28 |
$0.00 |
| 3008F |
|
100 |
92 |
$0.00 |